An Open-Label, Randomized, Parallel-Group Drug-Drug Interaction Study to Assess the Effect of Multiple Doses of Itraconazole or Gemfibrozil on the Pharmacokinetics of a Single Dose of JNJ-56021927 in Healthy Male Subjects
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Apalutamide (Primary) ; Gemfibrozil; Itraconazole
- Indications Prostate cancer; Salivary gland cancer
- Focus Pharmacokinetics
- Sponsors Aragon Pharmaceuticals; Janssen Research & Development
- 27 Apr 2020 Results from NCT02230033 (in healthy male) and NCT02592317 (prostate cancer) evaluating Pharmacokinetic Drug-Drug Interaction of Apalutamide, published in the Clinical Pharmacokinetics
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 09 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.